Skip to Main Content

Author Details

Shahrad Rod Rassekh
British Columbia Children's Hospital, The University of British Columbia
1998
105
25
PMIDPaper TitleJournal TitlePublished Year
36728273Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity.Ther Drug Monit2023
35748941Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countries.Pediatr Nephrol2023
36897636Outcomes of Coronavirus Disease 2019 Infection in Children and Adolescents With Cancer in Canada: Population-based Study and Systematic Review.J Pediatr Hematol Oncol2023
37022464Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review.Childs Nerv Syst2023
37016844Whole genome transcriptome analysis in a case of a neonatal soft tissue sarcoma with YWHAE:NUTM2B fusion.Pediatr Blood Cancer2023
37397090<i>RBL2</i> Regulates Cardiac Sensitivity to Anthracycline Chemotherapy.JACC CardioOncol2023
37134194Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial.Clin Cancer Res2023
36728273Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced Cardiotoxicity.Ther Drug Monit2023
36917731Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children.Ther Drug Monit2023
35748941Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countries.Pediatr Nephrol2023
37022464Outcomes of a radiation sparing approach in medulloblastoma by subgroup in young children: an institutional review.Childs Nerv Syst2023
37016844Whole genome transcriptome analysis in a case of a neonatal soft tissue sarcoma with YWHAE:NUTM2B fusion.Pediatr Blood Cancer2023
37134194Intravenous N-Acetylcysteine to Prevent Cisplatin-Induced Hearing Loss in Children: A Nonrandomized Controlled Phase I Trial.Clin Cancer Res2023
37397090<i>RBL2</i> Regulates Cardiac Sensitivity to Anthracycline Chemotherapy.JACC CardioOncol2023
36917731Role of Cisplatin Dose Intensity and TPMT Variation in the Development of Hearing Loss in Children.Ther Drug Monit2023
36897636Outcomes of Coronavirus Disease 2019 Infection in Children and Adolescents With Cancer in Canada: Population-based Study and Systematic Review.J Pediatr Hematol Oncol2023
34403168Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review.Child Care Health Dev2022
36143179A Systematic Review of Polygenic Models for Predicting Drug Outcomes.J Pers Med2022
33900042Pharmacogenetic testing to guide therapeutic decision-making and improve outcomes for children undergoing anthracycline-based chemotherapy.Basic Clin Pharmacol Toxicol2022
34403168Medicinal cannabis in children and adolescents with autism spectrum disorder: A scoping review.Child Care Health Dev2022
34672127Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer.Cancer Rep (Hoboken)2022
35149390A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women.Biomed Pharmacother2022
34490624The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.Cancer2022
36143179A Systematic Review of Polygenic Models for Predicting Drug Outcomes.J Pers Med2022
33900042Pharmacogenetic testing to guide therapeutic decision-making and improve outcomes for children undergoing anthracycline-based chemotherapy.Basic Clin Pharmacol Toxicol2022
35149390A pharmacogenomic investigation of the cardiac safety profile of ondansetron in children and pregnant women.Biomed Pharmacother2022
34672127Perspectives of pediatric oncologists and palliative care physicians on the therapeutic use of cannabis in children with cancer.Cancer Rep (Hoboken)2022
34490624The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments.Cancer2022
34121509Malignant Mesothelioma With <i>EWSR1-ATF1</i> Fusion in Two Adolescent Male Patients.Pediatr Dev Pathol2021
35368557Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury.Kidney3602021
34021014Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study.CMAJ Open2021
33749384Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.Pediatr Dev Pathol2021
34121509Malignant Mesothelioma With <i>EWSR1-ATF1</i> Fusion in Two Adolescent Male Patients.Pediatr Dev Pathol2021
33581749Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study.Lancet Child Adolesc Health2021
33727877Leptin is Associated with the Tri-Ponderal Mass Index in Children: A Cross-Sectional Study.Adolesc Health Med Ther2021
33939292Trametinib therapy for children with neurofibromatosis type 1 and life-threatening plexiform neurofibroma or treatment-refractory low-grade glioma.Cancer Med2021
33768871NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling.Clin Case Rep2021
34453400Vertebroplasty as a palliative treatment option for intractable pain in pediatric patients with spinal tumors.Pediatr Blood Cancer2021
34820133A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.Can J Kidney Health Dis2021
34931022Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.NPJ Precis Oncol2021
35368557Urine Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 to Detect Pediatric Cisplatin-Associated Acute Kidney Injury.Kidney3602021
33768871NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling.Clin Case Rep2021
33727877Leptin is Associated with the Tri-Ponderal Mass Index in Children: A Cross-Sectional Study.Adolesc Health Med Ther2021
33581749Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study.Lancet Child Adolesc Health2021
33749384Histologic Correlates of Molecular Group 4 Pediatric Medulloblastoma: A Retrospective Canadian Review.Pediatr Dev Pathol2021
34931022Clinical response to nivolumab in an INI1-deficient pediatric chordoma correlates with immunogenic recognition of brachyury.NPJ Precis Oncol2021
34820133A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research Protocol.Can J Kidney Health Dis2021
34453400Vertebroplasty as a palliative treatment option for intractable pain in pediatric patients with spinal tumors.Pediatr Blood Cancer2021
34021014Family attitudes about and experiences with medical cannabis in children with cancer or epilepsy: an exploratory qualitative study.CMAJ Open2021
33939292Trametinib therapy for children with neurofibromatosis type 1 and life-threatening plexiform neurofibroma or treatment-refractory low-grade glioma.Cancer Med2021
  • 1 - 50 of 210

Recommended Authors

Yu Liu
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital
Career Start Year 2015
Number of shared co-authors 3
Holly Lindsay
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 2012
Number of shared co-authors 8
Bhuvana A Setty
Ohio State University College of Medicine/Nationwide Children's Hospital
Career Start Year 2011
Number of shared co-authors 1
Amulya A Nageswara Rao
Mayo Clinic
Career Start Year 2009
Number of shared co-authors 11
Christopher C Porter
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Nicholas G Gottardo
Perth Children's Hospital
Career Start Year 2002
Number of shared co-authors 10
Cheng Cheng
St. Jude Children's Research Hospital
Career Start Year 2002
Number of shared co-authors 3
Noah Federman
University of California los angeles
Career Start Year 2001
Number of shared co-authors 3
Xueyuan Cao
University of Chinese Academy of Sciences
Career Start Year 2000
Number of shared co-authors 2
Todd A Alonzo
Keck School of Medicine, University of Southern California
Career Start Year 1999
Number of shared co-authors 7
Scott C Borinstein
Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 0
Rishi R Lulla
Hasbro Children's Hospital, Brown University.
Career Start Year 1997
Number of shared co-authors 11
Scott C Howard
College of Nursing
Career Start Year 1997
Number of shared co-authors 5
Ana Pati??o-Garc??a
Center for Applied Medical Research.
Career Start Year 1995
Number of shared co-authors 2
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 1
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 1993
Number of shared co-authors 13
Anne Bendel
Children's Hospitals and Clinics of Minnesota
Career Start Year 1993
Number of shared co-authors 15
Michael Weintraub
Hadassah Hebrew University Hospital
Career Start Year 1992
Number of shared co-authors 1
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Career Start Year 1991
Number of shared co-authors 23
Murali Chintagumpala
Texas Children's Cancer Center, Baylor College of Medicine
Career Start Year 1990
Number of shared co-authors 10
Maura Massimino
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 1990
Number of shared co-authors 16
Laurence Brugi??res
Universite Paris-Saclay
Career Start Year 1988
Number of shared co-authors 5
Fran??ois Doz
Institut Curie and University Paris Cite
Career Start Year 1987
Number of shared co-authors 13
Sue Hammond
Flinders University Library, Flinders University
Career Start Year 1985
Number of shared co-authors 2
Joseph P Neglia
Department of Pediatrics University of Minnesota Minneapolis MN.
Career Start Year 1984
Number of shared co-authors 2
Norbert Graf
Clinical Trials Unit
Career Start Year 1983
Number of shared co-authors 3
Mary V Relling
Departments of Pharmaceutical Sciences.
Career Start Year 1983
Number of shared co-authors 2
Brad H Pollock
University of California davis
Career Start Year 1983
Number of shared co-authors 1
Mark W Kieran
Boston Children's Hospital and Harvard Medical School
Career Start Year 1982
Number of shared co-authors 13
Gregory H Reaman
National Cancer Institute
Career Start Year 1978
Number of shared co-authors 14

Collaborators

Bruce C Carleton
BC Children's Hospital Research Institute
Co-authored papers 36
Michael R Hayden
Co-authored papers 18
Rebecca J Deyell
Co-authored papers 17
Janessa Laskin
Co-authored papers 11
Marco A Marra
University of British Columbia
Co-authored papers 10
Michael J Rieder
Schulich School of Medicine and Dentistry, University of Western Ontario
Co-authored papers 8
Steven J M Jones
University of British Columbia
Co-authored papers 8
Sylvia Cheng
Co-authored papers 4
Geoffrey D E Cuvelier
University of Manitoba
Co-authored papers 4
Sheila K Singh
McMaster University
Co-authored papers 4
Andrew J Mungall
Co-authored papers 4
Richard A Moore
Co-authored papers 4
Martin R Jones
BC Cancer Research Centre.
Co-authored papers 4
Tom D Blydt-Hansen
BC Children's Hospital, University of British Columbia
Co-authored papers 4
Michael Zappitelli
Toronto Hospital for Sick Children, University of Toronto
Co-authored papers 4
Jonathan L Finlay
Nationwide Children's Hospital and The Ohio State University
Co-authored papers 3
Amy Lum
University of British Columbia
Co-authored papers 3
Daniel Bernstein
Co-authored papers 3
David G Huntsman
University of British Columbia
Co-authored papers 3
Jacqueline E Schein
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 2
David Haussler
Genomics Institute, University of California Santa Cruz
Co-authored papers 2
Yussanne Ma
Co-authored papers 2
Yulia Newton
University of California, Santa Cruz Genomics Institute
Co-authored papers 2
Cheryl Ho
University of British Columbia
Co-authored papers 2
Girish Dhall
Co-authored papers 2
Alexandra P Zorzi
Western University
Co-authored papers 2
Teresa Swatloski
University of California
Co-authored papers 2
Lillian Sung
The Hospital for Sick Children
Co-authored papers 2
Jingchun Zhu
University of California at Santa Cruz
Co-authored papers 2
Sharon L Gardner
Co-authored papers 2
Release 1.2